Description
Immunotherapy marker for Pembrolizumab. Please specify the immunotherapy drug being planned and the site of biopsy. Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
PDL1- IHC
Immunotherapy marker for Pembrolizumab. Please specify the immunotherapy drug being planned and the site of biopsy. Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
TAT:
Specimen Type:
Immunohistochemistry Single Test
Other Tests
- 232%
- 228%
-
223%
Breast IHC Panel 4(ER PR HER2/NEU KI67)
Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
Breast IHC Panel 4(ER PR HER2/NEU KI67)
Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
-
227%
Calcitonin-IHC
Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
Calcitonin-IHC
Please send 1-2 representative H&E stained slides along with representative FFPE blocks.
Reviews
There are no reviews yet.